Crouzier Lucie, Diez Camille, Richard Elodie M, Cubedo Nicolas, Barbereau Clément, Rossel Mireille, Delaunay Thomas, Maurice Tangui, Delprat Benjamin
MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.
IES, Univ Montpellier, CNRS, Montpellier, France.
Front Cell Dev Biol. 2021 May 20;9:675517. doi: 10.3389/fcell.2021.675517. eCollection 2021.
Retinitis pigmentosa (RP) is one of the most common forms of inherited retinal degeneration with 1/4,000 people being affected. The vision alteration primarily begins with rod photoreceptor degeneration, then the degenerative process continues with cone photoreceptor death. Variants in 71 genes have been linked to RP. One of these genes, is responsible for RP43. To date no treatment is available and patients suffer from pronounced visual impairment in early childhood. We used the novel zebrafish mutant, generated by N-ethyl-N-nitrosourea at the European Zebrafish Resource Centre, to better understand how PDE6a loss of function leads to photoreceptor alteration. Interestingly, zebrafish mutants exhibited impaired visual function at 5 dpf as evidenced by the decrease in their visual motor response (VMR) compared to larvae. This impaired visual function progressed with time and was more severe at 21 dpf. These modifications were associated with an alteration of rod outer segment length at 5 and 21 dpf. In summary, these findings suggest that rod outer segment shrinkage due to Pde6a deficiency begins very early in zebrafish, progresses with time. The zebrafish mutant represents an ideal model of RP to screen relevant active small molecules that will block the progression of the disease.
视网膜色素变性(RP)是最常见的遗传性视网膜变性形式之一,每4000人中就有1人受其影响。视力改变主要始于视杆光感受器变性,然后变性过程随着视锥光感受器死亡而继续。71个基因的变异与RP有关。其中一个基因 导致了RP43。迄今为止,尚无治疗方法,患者在幼儿期就会出现明显的视力损害。我们使用了由欧洲斑马鱼资源中心通过N-乙基-N-亚硝基脲产生的新型斑马鱼 突变体,以更好地了解PDE6a功能丧失如何导致光感受器改变。有趣的是,斑马鱼 突变体在5 dpf时表现出视觉功能受损,与 幼虫相比,其视觉运动反应(VMR)降低证明了这一点。这种受损的视觉功能随时间推移而进展,在21 dpf时更为严重。这些改变与5和21 dpf时视杆外段长度的改变有关。总之,这些发现表明,由于Pde6a缺乏导致的视杆外段收缩在斑马鱼中很早就开始了,并随时间进展。斑马鱼 突变体代表了一个理想的RP模型,用于筛选能够阻止疾病进展的相关活性小分子。